Uquifa

Uquifa, established in 1936, operates as a specialized manufacturer within the global pharmaceutical and healthcare sectors. The company focuses on the production of Active Pharmaceutical Ingredients (API) and provides comprehensive Contract Development and Manufacturing Organization (CDMO) services. As the dedicated API business unit of Vivimed Labs Limited, Uquifa leverages extensive industry expertise to serve both Generic API and CDMO API market segments. The organization maintains a robust operational framework that supports complex chemical synthesis and pharmaceutical manufacturing requirements, ensuring compliance with international quality standards.

The company currently sustains a workforce of 500-1,000 employees who drive its technical and operational initiatives. Meet Uquifa's team to understand the organizational structure and the specialized talent behind their pharmaceutical manufacturing processes. With a strategic focus on operational efficiency, Uquifa manages its production capabilities to meet the rigorous demands of the global healthcare market. The company’s commitment to technical excellence is reflected in its long-standing history and its ability to adapt to evolving industry needs, maintaining a consistent output of high-quality pharmaceutical ingredients.

Uquifa operates with a primary facility located in Barcelona, Spain, serving as a central hub for its European and global activities. The company’s manufacturing footprint extends across Spain and Mexico, facilitating a broad reach within the pharmaceutical supply chain. By integrating advanced chemical engineering with specialized pharmaceutical knowledge, Uquifa continues to strengthen its position as a key player in the API and CDMO sectors. The firm’s business model emphasizes the delivery of high-value chemical solutions, supporting the development and production of essential healthcare products.